Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement next-generation sequencing (NGS) for precise patient stratification and ...

co-leader of VHIO's Prostate Cancer Group, and co-corresponding author of this study. "However, several challenges of NGS testing still impede the widespread implementation of precision medicine ...

Jointly developed by investigators of the Vall d'Hebron Institute of Oncology's (VHIO) Radiomics Group and the Bellvitge University Hospital's Neuroradiology Unit, the Diagnosis in Susceptibility ...